AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
(Reuters) – Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 p..
News
News
The importance of financial education in empowering consumers
Q1: Why is financial education important? A1: Financial education is essential because it empowers individuals to make inform..
News
The benefits of green energy for businesses
..
News
News
Evonik says recovery unlikely in 2024, plans 2,000 job cuts
Evonik says recovery unlikely in 2024, plans 2,000 job cuts
..
News
Facing Chinese EV rivals, Europe’s automakers squeeze suppliers on costs
Many legacy suppliers are already feeling the strain of cost cuts with Forvia, Continental and Bosch all recently announcing or warni..
News
Jet engine maker Safran raises dividend on profit jump and growth outlook
..
News
Gucci’s new designer in focus as Kering plots future growth
..
News
China’s exchanges restrict stock selling by some hedge funds
..
News
Dollar scales fresh peaks as Fed cut bets recede
..
News
Euro zone economy lags global growth as Germany struggles
..
News